![Francesco de Rubertis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francesco de Rubertis
Vorsitzender bei
CENTESSA PHARMACEUTICALS PLC
Profil
Francesco de Rubertis is the founder of Medicxi Ventures (Jersey) Ltd., holding the title of Partner since 2015.
Current jobs include Chairman at Centessa Pharmaceuticals Plc since 2020, Director at Hamilton Pharmaceuticals, Inc., Director at Genebiotech Co., Ltd., Director at the University of Geneva, Non-Executive Director at Xenikos BV since 2018, Director at Egalet A, Director at Levicept Ltd., Director at Critical Pressure Ltd., Director at Rivus Pharmaceuticals, Inc., Director at Centessa Pharmaceuticals (Orexia) Ltd. since 2018, Director at Synox Therapeutics Ltd., Director at SDS Therapeutics Ltd. since 2020, Director at Ottimo Pharma Ltd., and Director at Alys Pharmaceuticals, Inc. Former jobs include Chairman at PanGenetics BV, Non-Executive Director at BioXell SpA from 2011 to 2012, Director at Cellzome Ltd., Director at ParAllele BioScience, Inc., Director at NormOxys, Inc., Director at Zyla Life Sciences LLC, Director at Genmab A, Director at CareX SA, Director at Addex Therapeutics Ltd., Director at Egalet Ltd., Director at 7TM A, Director-Executive Board at GlycoVaxyn AG in 2009, Non-Executive Director at Molecular Partners AG, Director-Investor Relations at SpinX Technologies SA, Director at UltraHuman Ltd. from 2020 to 2023, Director at Cyrenaic Pharmaceuticals, Inc., Independent Director at Versartis, Inc. in 2014, Independent Director at Minerva Neurosciences, Inc. from 2014 to 2017, Director at Inexia Ltd., Board Observer at Sequenta, Inc., Member-Supervisory Board at Profibrix BV in 2011, and Partner at Index Ventures (UK) LLP from 1998 to 2016.
Education includes an undergraduate degree from the University of Pavia and a doctorate from the University of Geneva.
Aktive Positionen von Francesco de Rubertis
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Vorsitzender | 01.11.2020 |
Egalet A/S
 Egalet A/S Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceuticals company | Direktor/Vorstandsmitglied | - |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Gründer | 03.11.2015 |
Orexia Therapeutics Ltd.
 Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Direktor/Vorstandsmitglied | 05.10.2018 |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Direktor/Vorstandsmitglied | 18.12.2020 |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Develops treatments for osteoarthritis and chronic pain | Direktor/Vorstandsmitglied | - |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Develops medicines based on the action of antibodies | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Francesco de Rubertis
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Francesco de Rubertis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
37
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 37 |
|---|---|
Hamilton Pharmaceuticals, Inc.
 Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and supplies pharmaceuticals | Commercial Services |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and manufactures drugs | Health Technology |
ParAllele BioScience, Inc.
 ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Commercial Services |
Genebiotech Co., Ltd.
 Genebiotech Co., Ltd. BiotechnologyHealth Technology Develops gene and cell-based machines | Health Technology |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
PanGenetics BV
 PanGenetics BV Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody-based therapeutic products | Commercial Services |
CareX SA
 CareX SA Pharmaceuticals: MajorHealth Technology Develops drugs for metabolic disorders | Health Technology |
Addex Therapeutics Ltd.
 Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Pavia
 University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
7TM A/S
 7TM A/S BiotechnologyHealth Technology Operates as a biotech company that discovers and develops drugs | Health Technology |
GlycoVaxyn AG
 GlycoVaxyn AG BiotechnologyHealth Technology Developed and produced bioconjugate vaccines | Health Technology |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
SpinX Technologies SA
 SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Health Technology |
Cyrenaic Pharmaceuticals, Inc.
 Cyrenaic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides and develops drugs | Health Technology |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Index Ventures (UK) LLP
 Index Ventures (UK) LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Xenikos BV
Xenikos BV Medical SpecialtiesHealth Technology Develops medicines based on the action of antibodies | Health Technology |
Egalet A/S
Egalet A/S Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceuticals company | Health Technology |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Levicept Ltd.
Levicept Ltd. Pharmaceuticals: GenericHealth Technology Develops treatments for osteoarthritis and chronic pain | Health Technology |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
UltraHuman Ltd.
 UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Critical Pressure Ltd.
 Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products to treat vascular dysfunction and shock | Health Technology |
Inexia Ltd.
 Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Health Technology |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Commercial Services |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
SDS Therapeutics Ltd.
SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Ultrahuman Eight Ltd.
 Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Health Technology |
